Cas:1085273-49-9 23S-hydroxyl-11,15-dioxo-ganoderic acid DM manufacturer & supplier

Chemical Name:23S-hydroxyl-11,15-dioxo-ganoderic acid DM

CAS.NO:1085273-49-9

Synonyms:(5ξ,23S,24E)-23-Hydroxy-3,7,11,15-tetraoxolanosta-8,24-dien-26-oic acid;Lanosta-8,24-dien-26-oic acid, 23-hydroxy-3,7,11,15-tetraoxo-, (5ξ,23S,24E)-

Molecular Formula:C₃₀H₄₀O₇

Molecular Weight:512.634

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:700.4±60.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.570

PSA:

Exact Mass:512.277405

LogP:3.31

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (5ξ,23S,24E)-23-Hydroxy-3,7,11,15-tetraoxolanosta-8,24-dien-26-oic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Lanosta-8,24-dien-26-oic acid, 23-hydroxy-3,7,11,15-tetraoxo-, (5ξ,23S,24E)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(5ξ,23S,24E)-23-Hydroxy-3,7,11,15-tetraoxolanosta-8,24-dien-26-oic acid Use and application,Lanosta-8,24-dien-26-oic acid, 23-hydroxy-3,7,11,15-tetraoxo-, (5ξ,23S,24E)- technical grade,usp/ep/jp grade.

Related News: The Department of Health and Human Services asked the Defense Department to provide several facilities capable of housing at least 250 people in individual rooms through to February 29, the Pentagon said. 23S-hydroxyl-11,15-dioxo-ganoderic acid DM manufacturer The Department of Health and Human Services asked the Defense Department to provide several facilities capable of housing at least 250 people in individual rooms through to February 29, the Pentagon said. 23S-hydroxyl-11,15-dioxo-ganoderic acid DM supplier In the first round of nationwide implement of the program, in September, multinationals including Sanofi and Eli Lilly managed to cut some prices low enough to levels close to those offered by local generic makers. 23S-hydroxyl-11,15-dioxo-ganoderic acid DM vendor The CRL for the Cabenuva injection, containing two active ingredients cabotegravir and Janssen��s rilpivirine, follows U.S. market approval in April for its once-a-day pill Dovato, also a two-drug combination. 23S-hydroxyl-11,15-dioxo-ganoderic acid DM factory In the first round of nationwide implement of the program, in September, multinationals including Sanofi and Eli Lilly managed to cut some prices low enough to levels close to those offered by local generic makers.